Jun Qu Selected Research

birinapant

10/2020	Pharmacodynamic modeling of synergistic birinapant/paclitaxel interactions in pancreatic cancer cells.
1/2018	Temporal Effects of Combined Birinapant and Paclitaxel on Pancreatic Cancer Cells Investigated via Large-Scale, Ion-Current-Based Quantitative Proteomics (IonStar).
1/2018	Proteomic Analysis of Combined Gemcitabine and Birinapant in Pancreatic Cancer Cells.
1/2018	Multi-Scale Network Model Supported by Proteomics for Analysis of Combined Gemcitabine and Birinapant Effects in Pancreatic Cancer Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jun Qu Research Topics

Disease

15	Neoplasms (Cancer) 01/2022 - 11/2008
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 01/2018
5	Infections 10/2019 - 02/2016
5	Multiple Sclerosis 09/2014 - 03/2010
4	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2013
3	Chronic Obstructive Pulmonary Disease (COPD) 05/2022 - 06/2010
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 06/2011
3	Inflammation (Inflammations) 10/2019 - 11/2009
3	Hypoxia (Hypoxemia) 10/2019 - 05/2015
3	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 04/2008
2	Macular Degeneration (Age-Related Maculopathy) 01/2022 - 01/2020
2	Liver Neoplasms (Liver Cancer) 11/2020 - 09/2020
2	Urinary Bladder Neoplasms (Bladder Cancer) 11/2020 - 01/2018
2	Adenocarcinoma 10/2020 - 01/2019
2	Melanoma (Melanoma, Malignant) 03/2019 - 01/2018
2	Consciousness Disorders 01/2019 - 01/2017
2	Starvation 12/2018 - 01/2016
2	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 11/2017
2	Disease Progression 09/2014 - 11/2013
1	Lung Diseases (Lung Disease) 08/2022
1	Hemorrhage 05/2022
1	Atrial Fibrillation 05/2022
1	Pericardial Effusion 05/2022
1	Appendicitis 04/2021
1	Traumatic Brain Injuries (Traumatic Brain Injury) 02/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Autistic Disorder (Autism) 01/2021
1	Gallstones (Gallstone) 09/2020
1	Cholelithiasis 01/2020
1	Obesity 01/2020
1	Myocardial Stunning (Stunned Myocardium) 01/2020
1	Blindness (Hysterical Blindness) 10/2019
1	Malnutrition (Nutritional Deficiencies) 10/2019
1	Fatigue 08/2019
1	Esophageal Squamous Cell Carcinoma 01/2019
1	Metabolic Diseases (Metabolic Disease) 01/2019
1	Esophageal Neoplasms (Esophageal Cancer) 01/2019
1	African Trypanosomiasis (Nagana) 12/2018

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 05/2022 - 07/2007
10	ProteomeIBA 05/2022 - 06/2011
5	Biomarkers (Surrogate Marker)IBA 08/2022 - 02/2014
5	Pharmaceutical PreparationsIBA 05/2022 - 11/2008
5	Vitamin D FDA LinkGeneric 05/2017 - 03/2010
4	birinapantIBA 10/2020 - 01/2018
4	Paclitaxel (Taxol)FDA LinkGeneric 10/2020 - 11/2008
3	Biological ProductsIBA 01/2022 - 08/2011
3	CholesterolIBA 01/2016 - 12/2013
2	AndrogensIBA 01/2021 - 01/2018
2	Serine (L-Serine)FDA Link 01/2021 - 09/2016
2	C-Reactive ProteinIBA 11/2020 - 01/2020
2	Retinaldehyde (Retinal)IBA 01/2020 - 10/2019
2	Drug CombinationsIBA 10/2019 - 01/2018
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2019 - 01/2019
2	MicroRNAs (MicroRNA)IBA 03/2019 - 01/2018
2	LipidsIBA 01/2019 - 11/2013
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 01/2019
2	Gemcitabine FDA Link 01/2018 - 01/2018
2	Monoclonal AntibodiesIBA 01/2018 - 01/2018
2	Troponin IIBA 01/2018 - 04/2017
2	hydroxide ionIBA 05/2017 - 02/2011
2	Amino Acids FDA Link 11/2014 - 07/2007
1	GoldIBA 05/2022
1	Estrogen ReceptorsIBA 01/2022
1	isothiocyanic acidIBA 01/2022
1	IsothiocyanatesIBA 01/2022
1	Epidermal Growth Factor (EGF)IBA 01/2022
1	InflammasomesIBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2022
1	fibrin fragment D (D-dimer)IBA 04/2021
1	Methamphetamine (Desoxyn)FDA LinkGeneric 02/2021
1	Guanylate KinasesIBA 01/2021
1	CalciumIBA 01/2021
1	CarcinogensIBA 01/2021
1	Protein Kinases (Protein Kinase)IBA 01/2021
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2021
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2021
1	Cullin Proteins (Cullins)IBA 01/2021
1	SurvivinIBA 11/2020
1	7- ethyl- 7- hydroxy- 10H- 1,3- Dioxolo(4,5- g)pyrano(3',4':6,7)indolizino(1,2- b)quinoline- 8,11(7H,12H)- dioneIBA 11/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2020
1	CaspasesIBA 10/2020
1	Oxygen (Dioxygen)IBA 10/2019
1	LubricantsIBA 08/2019
1	Ionic LiquidsIBA 08/2019
1	DeoxyuridineIBA 01/2019
1	PhosphoenolpyruvateIBA 01/2019
1	phosphohistidineIBA 01/2019
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2019
1	Radioisotopes (Radionuclides)IBA 01/2019
1	Bromodeoxyuridine (BrdU)IBA 01/2019
1	Nucleic AcidsIBA 12/2018
1	Arginine (L-Arginine)FDA Link 12/2018

Therapy/Procedure

5	Therapeutics 11/2020 - 12/2008
2	Drug Therapy (Chemotherapy) 11/2020 - 01/2018
2	Cholecystectomy 09/2020 - 01/2020
1	Perioperative Period 05/2022
1	Catheter Ablation 05/2022
1	Radiotherapy 11/2020
1	Brain-Computer Interfaces 01/2019